Interestingly, similar to Mentz et al., our study identified the use of aldosterone antagonists and higher EF as positive predictors of torsemide use in HF (OR = 1.97, 95% CI 1.59–2.44, p = < 0.0001; OR = 1.10, 95% CI = 1.07–1.14, p = < 0.0001; respectively), and increased age along with ACE inhibitor use as negative predictors of torsemide use (OR = 0.92, 95% CI 0.89–0.96, p = < 0.0001; OR = 0.78, 95% Cl 0.63–0.95, p = 0.015; respectively) [12]. Here, ACE is linked to hydrops fetalis.